| Literature DB >> 26913144 |
Mariah R Baker1, Guizhen Fan1, Irina I Serysheva1.
Abstract
Ryanodine receptors (RyRs) are tetrameric ligand-gated Ca(2+) release channels that are responsible for the increase of cytosolic Ca(2+) concentration leading to muscle contraction. Our current understanding of RyR channel gating and regulation is greatly limited due to the lack of a high-resolution structure of the channel protein. The enormous size and unwieldy shape of Ca(2+) release channels make X-ray or NMR methods difficult to apply for high-resolution structural analysis of the full-length functional channel. Single-particle electron cryo-microscopy (cryo-EM) is one of the only effective techniques for the study of such a large integral membrane protein and its molecular interactions. Despite recent developments in cryo-EM technologies and break-through single-particle cryo-EM studies of ion channels, cryospecimen preparation, particularly the presence of detergent in the buffer, remains the main impediment to obtaining atomic-resolution structures of ion channels and a multitude of other integral membrane protein complexes. In this review we will discuss properties of several detergents that have been successfully utilized in cryo-EM studies of ion channels and the emergence of the detergent alternative amphipol to stabilize ion channels for structure-function characterization. Future structural studies of challenging specimen like ion channels are likely to be facilitated by cryo-EM amenable detergents or alternative surfactants.Entities:
Keywords: Amphipol; Cryospecimen preparation; Detergents; Electron cryo-microscopy; Membrane proteins; Ryanodine receptor
Year: 2015 PMID: 26913144 PMCID: PMC4748972 DOI: 10.4081/ejtm.2015.4803
Source DB: PubMed Journal: Eur J Transl Myol ISSN: 2037-7452
Fig 1.Timeline summary of RyR1 structural studies.
RyR1 was first identified as large electron-dense “foot” observed between the junctions of T-tubule and SR membranes.[25] Over the next two decades many efforts were made to molecularly identify the structure observed in the triad junctions and its role in muscle physiology.
Eventually, through the use of [3]H-ryanodine, differential centrifugation and biophysical characterizations, RyR1 was solidified as the intracellular Ca2+ release channel responsible for the release of Ca2+ preceding muscle contraction.[27-29] Due to its relative ease of purification and large size, the structure of RyR1 was investigated by single-particle electron-microscopy. The first 3D structure was obtained by negative stain microscopy, reveling basic morphological features, albeit in a stained and dehydrated state.[33] The first depictions of RyR1 in the more native, hydrated conditions came ~4 years later by cryo-EM and were solved to ~30 Å resolution.[34,36] Low-resolution structural dynamics of RyR1 gating were described by adding ligands that affect channel open probability to the cryospecimen prior to virtification.[54,55] Several additional low-resolution structures of RyR1 were solved that localized small molecule binding sites (CaM, FKBP12 and imperatoxin) and functional domains on the 3D structure of RyR1.[46,47,50-53] Structures of RyR2 and RyR3 isoforms were also determined by cryo-EM and appear similar in nature to RyR1. [43,45] In two decades since the first structure of RyR1 by cryo-EM was determined, ~1 nm resolution structures were obtained and density based models of channel gating were proposed.[37,40] Homology models for the N-terminal domain of the channel were created based on structures of the IP[3]R1 N-terminus and computationally fitted to the map [38,39] Several secondary structure elements in the cytoplasmic and transmembrane domains and subunit boundaries were detectable resulting in a molecular model for some transmembrane helices. Gating induced structural changes were investigated in a ~1 nm resolution structure.[41] Structural models for three disease hot-spot domains were determined by X-ray crystallography: the RyR1 N-terminal domain (residues 1-559; PDB: 2XOA), phosphorylation domain (residues 2734-2940; PDB: 4ERT) and SPRY2 domain (residues 1070-1246; PDB: 4P9I, 4P9J, 4P9L).[59,60,82,98] With state of the art imaging technology in place, the future for the Ca2+ release channel is ripe to proceed towards near-atomic resolutions.
Fig 2.3D structures of the tetrameric RyR1 channel determined by cryo-EM.
Surface representations of RyR1 density maps by single-particle cryo-EM viewed in three orthogonal views – from cytoplasm (top), along the membrane plane (middle) and from luminal side (bottom) of the membrane. Left to right are RyR1 density maps at 14 Å (EMD-1274), 10.2 Å (EMD-5014) and 9.6 Å (EMD-1275) resolutions.[37,38,40]
Detergent properties used in single-particle cryo-EM of ion channels. The physical properties of used detergents including CMC, micelle size and molecular weight are important considerations when optimizing cryospecimen conditions.
| Detergent | CMC (mM) | CMC (%w/v) | Micelle Size (Da) | Molecular Weight | Aggregation Number |
|---|---|---|---|---|---|
| 8 | 0.5 | 6,150 | 615 | 10 | |
| 0.22-0.24 | 0.01-0.016 | 90,000 | 625 | 100-155 | |
| <0.5 | 0.02 | 70,000 | 1,229 | 60 | |
| 0.17 | 0.0087 | 72,000 | 511 | 78-149 | |
| 1.8 | 0.087 | 33,000 | 483 | 98 | |
| 23-25 | 0.67-0.73 | 8,000 | 292 | 27-100 |
Attributes of membrane protein complexes determined by single-particle cryo-EM. A summary of membrane protein structural studies and cryospecimen surfactants used. Listed for each macromolecular complex is the: molecular weight, EMDataBank [EMD] identification number, when available, author’s reported resolution (Å) and surfactant type and amount present in cryospecimen.
| Membrane Protein | M.W. (Mda) | EMDB ID | Resolution (Å) | Surfactant and amount reported in cryospecimen | Refs. | ||
|---|---|---|---|---|---|---|---|
| Surfactant | Amt | x CMC | |||||
| RyR1 | 2.3 | 1274 | 14 | CHAPS | 0.40% | 0.8-1 | [ |
| 1275 | 9.6 | CHAPS | 0.40% | 0.8-1 | [ | ||
| 5014 | 10.3 | CHAPS | 0.50% | 1 | [ | ||
| 1607, 1606 | 10.2 | CHAPS | 0.50% | 1 | [ | ||
| IP3R1 | 1.3 | — | 24 | CHAPS | 0.40% | 0.8-1 | [ |
| — | 30 | Triton X-100 | 0.15% | >10 | [ | ||
| 5278 | 10 | CHAPS | 0.40% | 0.8-1 | [ | ||
| 1061 | 20 | CHAPS | 1% | 2 | [ | ||
| DHPR (CaV1.1) | 0.55 | 25 | Digitonin | 0.10% | 5 | [ | |
| 1069 | 25 | Digitonin | 0.10% | 5 | [ | ||
| TRPC3 | 0.388 | 15 | DM | 5 mM | 2.7 | [ | |
| TRPV4 | 0.39 | 35 | DDM | 1 mM | 5.9 | [ | |
| TRPV1 | 0.3 | 19 | DM | 0.1% | 1.15 | [ | |
| TRPV1 | 0.3 | 5778 | 3.27 | Apol | 1:3 | — | [ |
| TRPV1 | 0.3 | 5776, 5777 | 3.8 | Apol | 1:3 | [ | |
| TRPV2 | 0.36 | 5688 | 13.6 | decyl-MNG | 0.006% | 1.8 | [ |
| TRPA1 | 0.525 | 5334 | 16 | A8-35 | 1:2.3 | [ | |
| KVAP-Fab | 0.3 | 1094 | 10.5 | DM | 5mM | 2.7 | [ |
| MCA channel | 0.2 | 2313 | 26 | Ammonium perfluoro-octanoate | 4% | 3.4 | [ |
| GluR | 0.37 | 2680 | 10.4 | DDM | 0.75 mM | 4.4 | [ |
| γ-Secretase | 0.17 | 2677, 2678 | 4.5 | A8-35 | 1:3 | [ | |
| ATPase | 0.6 | 5335 | 9.7 | DDM | 0.02% | 2.3 | [ |
| 0.9 | 5476 | 11 | DDM | 0.03% | 3.4 | [ | |
Fig 3.Cryo-EM images of ice-embedded purified RyR1: in the presence of 0.4 % CHAPS (A) in the presence of A8-35 (B); in the presence of A8-35/n-octyl glucoside [OG]. Note preferred orientation of RyR1 particles in (B), while the particles are randomly oriented within the vitreous ice due to achieved optimal protein/Apol8-35/OG ratio in the cryospecimen shown in (C). Images were recorded on a Gatan 4k x 4k CCD camera using JEM2010F cryomicroscope operated under minimal electron dose conditions (~20 e-/Å[2]).
Scale bars are 500 Å.
Fig 4.Scatchard analysis of [[3]H]-ryanodine binding to RyR1: in skeletal muscle SR membranes (•), purified RyR1 bound to CHAPS (▲) and 800 purified RyR1 in complex with A8-35 (■). Linear fitting yielded Kd of 1.99 nM and Bmax of 60.4 pmol/mg of protein for RyR1/A8-35, and Kd of 41.27 nM and Bmax of 3.07 pmol/mg for RyR1/CHAPS and Kd of 2.54 nM and Bmax of 27.9 pmol/mg for SR membranes in high Ca2+ conditions (200μM Ca2+), indicating that the high-affinity binding site for ryanodine is retained in RyR1/Apol and similar to that of RyR1 embedded within the SR membrane.